SG Americas Securities
DRIO icon

SG Americas Securities’s DarioHealth DRIO Stock Holding History

SG Americas Securities’s Portfolio DRIO Stock Details DRIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-426
Closed -$116K – 3484
2021
Q3 		$116K Buy
+426
New +$123K ﹤0.01% 3591

Other funds holding DRIO

CHM
Collaborative Holdings Management New York $49.2M AUM 119.38% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
LC
L1 Capital Melbourne VIC 3000, Australia $2.55B AUM 80.12% 1-Year Est. Return
AWAM
Appian Way Asset Management New York $558M AUM 1.95% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SG Americas Securities's DRIO Position: Q4 2021 in Review

SG Americas Securities sold out of DarioHealth (DRIO) in Q4 2021, closing a stake of 426 shares — an estimated $116K sold.

SG Americas Securities first reported a position in DRIO in Q3 2021 and held it in 1 quarter. The position peaked at $116K in Q3 2021. 60 funds tracked by Wall St. Rank hold DRIO as of Q4 2021.

  • SG Americas Securities reported no remaining DarioHealth position as of Q4 2021 after selling out during the quarter.
  • SG Americas Securities sold 426 DarioHealth shares in Q4 2021, an estimated $116K.
  • SG Americas Securities first reported a position in DarioHealth in Q3 2021 and held it in 1 quarter.
  • SG Americas Securities's DarioHealth position peaked at $116K in Q3 2021.
  • 60 funds tracked by Wall St. Rank held DarioHealth as of Q4 2021.

Based on SG Americas Securities's 13F filing for Q4 2021, filed 7 Feb 2022.